These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 26264934)
1. Debilitating fatigue as a treatment indication in chronic hepatitis C. Hjerrild S; Dalgard O; Christensen PB; Leutscher P J Hepatol; 2015 Dec; 63(6):1533-4. PubMed ID: 26264934 [No Abstract] [Full Text] [Related]
2. Reply to "Debilitating fatigue as a treatment indication in chronic hepatitis C". Gerber L; Younossi Z J Hepatol; 2015 Dec; 63(6):1534-5. PubMed ID: 26375244 [No Abstract] [Full Text] [Related]
3. Reply to "Debilitating fatigue as a treatment indication in chronic hepatitis C". Pawlotsky JM; Aghemo A; Back D; Dusheiko G; Forns X; Puoti M; Sarrazin C; J Hepatol; 2015 Dec; 63(6):1535-6. PubMed ID: 26375242 [No Abstract] [Full Text] [Related]
4. EASL Recommendations on Treatment of Hepatitis C 2015. European Association for Study of Liver J Hepatol; 2015 Jul; 63(1):199-236. PubMed ID: 25911336 [No Abstract] [Full Text] [Related]
5. Hepatitis C screening and evaluation: clinical decision tool. Allen JI Gastroenterology; 2013 Nov; 145(5):1144-5. PubMed ID: 24139702 [No Abstract] [Full Text] [Related]
6. [Should hepatitis C be treated? Value of hepatic biopsy in the management of patients with chronic hepatitis C virus infection?]. Deugnier Y Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S51-6. PubMed ID: 9161514 [No Abstract] [Full Text] [Related]
7. Updated recommendations for diagnosis and management of the US population for hepatitis C. Bragg J J Am Osteopath Assoc; 2013 Jun; 113(6):445-6. PubMed ID: 23739753 [No Abstract] [Full Text] [Related]
8. [The indication and the evaluation of IFN treatment of chronic hepatitis C]. Yano M Nihon Rinsho; 1994 Jul; 52(7):1778-83. PubMed ID: 7521417 [TBL] [Abstract][Full Text] [Related]
9. Management of chronic hepatitis B and C. Dusheiko GM S Afr Med J; 1994 Aug; 84(8 Pt 2):563-70. PubMed ID: 7863401 [No Abstract] [Full Text] [Related]
10. Economic modeling of treatment in chronic hepatitis B and chronic hepatitis C: promises and limitations. Koff RS; Seeff LB Hepatology; 1995 Dec; 22(6):1880-2. PubMed ID: 7490001 [No Abstract] [Full Text] [Related]
11. [How should hepatitis C be treated? Treatment of chronic hepatitis C with therapeutic combinations]. Brissot P Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S89-95. PubMed ID: 9161519 [No Abstract] [Full Text] [Related]
12. [Treatment of hepatitis C]. Schrumpf E; Bjøro K; Bell H; Harthug S; Hellum KB; Myrvang B; Maeland A; Ritland S Tidsskr Nor Laegeforen; 1996 Jun; 116(15):1792-4. PubMed ID: 8693463 [TBL] [Abstract][Full Text] [Related]
13. Interferon and other therapies for hepatitis B and hepatitis C infections. Rothstein KD; Munoz SJ Clin Lab Med; 1996 Jun; 16(2):465-91. PubMed ID: 8792083 [TBL] [Abstract][Full Text] [Related]
15. [Should hepatitis C be treated? What are indications of treatment in chronic hepatitis C?]. Pascal JP Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S70-9. PubMed ID: 9161517 [No Abstract] [Full Text] [Related]
16. Treatment of hepatitis C. Kim AI; Saab S Am J Med; 2005 Aug; 118(8):808-15. PubMed ID: 16084169 [TBL] [Abstract][Full Text] [Related]
17. An international survey of the diagnosis, management, and treatment of hepatitis C in patients with end-stage renal disease. Olson MR; Grewal KS; Bingaman A; Zaki R; Stewart S; Horton J; Araya V; Ortiz J Exp Clin Transplant; 2009 Dec; 7(4):203-13. PubMed ID: 20353368 [TBL] [Abstract][Full Text] [Related]
18. Interferon therapy in hepatitis C--refractory hepatitis--report of the research subgroup of treatment of chronic hepatitis. Iino S Gastroenterol Jpn; 1993 Mar; 28 Suppl 4():139-42. PubMed ID: 8486225 [No Abstract] [Full Text] [Related]
19. [Prediction of the outcome of IFN therapy in type C chronic hepatitis from serological grouping of hepatitis C virus]. Sakai A; Yanagi M; Unoura M; Kobayashi K Nihon Rinsho; 1994 Jul; 52(7):1759-62. PubMed ID: 7521415 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of chronic viral hepatitis]. Ferraz ML; Lopes EP; Adania RS; de Oliveira PM; Silva AE; Guimarães RX Rev Assoc Med Bras (1992); 1993; 39(2):107-14. PubMed ID: 7694730 [No Abstract] [Full Text] [Related] [Next] [New Search]